177lu-psma-617
novartis
['crpc', '68g']
[68ga]ga-psma-11 pet baseline imaging as a prognostic tool for clinical outcomes to [177lu]lu-psma-617 in patients with #mcrpc: a #vision substudy. presentation by . #asco22 written coverage by &gt; 
Largest global online community of #urological medical professionals & patients. #AUA22 #bladdercancer #menshealth #prostatecancer #kidneycancer #Urology